In 566 patients with non-large vessel occlusion ischaemic stroke and salvageable tissue 4.5–24 h after onset, IV tenecteplase vs standard treatment raised excellent outcome (mRS 0–1) at 90 days, 43.6% vs 34.2% (RR 1.28), but symptomatic ICH was 2.8% vs 0%.
RCTn = 566
Ma et al. Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke: The OPTION Randomized Clinical Trial